Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

3,91 valoración promedio
( 95 valoraciones por GoodReads )
 
9780812991840: Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

Los mejores resultados en AbeBooks

1.

Bazell, Robert
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos Cantidad: > 20
Librería
BWB
(Valley Stream, NY, Estados Unidos de America)
Valoración
[?]

Descripción Estado de conservación: New. Depending on your location, this item may ship from the US or UK. Nº de ref. de la librería 97808129918400000000

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 11,05
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

2.

Bazell, Robert
Editorial: Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos PAPERBACK Cantidad: > 20
Librería
Mediaoutlet12345
(Springfield, VA, Estados Unidos de America)
Valoración
[?]

Descripción Random House. PAPERBACK. Estado de conservación: New. 0812991842 *BRAND NEW* Ships Same Day or Next!. Nº de ref. de la librería SWATI2122086469

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 7,64
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,68
A Estados Unidos de America
Destinos, gastos y plazos de envío

3.

BAZELL, ROBERT
Editorial: Penguin Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos Cantidad: > 20
Librería
INDOO
(Avenel, NJ, Estados Unidos de America)
Valoración
[?]

Descripción Penguin Random House. Estado de conservación: New. Brand New. Nº de ref. de la librería 0812991842

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 8,28
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,23
A Estados Unidos de America
Destinos, gastos y plazos de envío

4.

Robert Bazell
Editorial: Random House USA Inc, United States (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos Paperback Cantidad: 1
Librería
The Book Depository
(London, Reino Unido)
Valoración
[?]

Descripción Random House USA Inc, United States, 1998. Paperback. Estado de conservación: New. 226 x 150 mm. Language: English . Brand New Book. Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield s aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech s clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn t otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient s bedside. Bazell s deft portraits introduce us to the remarkable people instrumental in Herceptin s history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon s research; and Marti Nelson, who inspired the activists who lobbied for a compassionate use program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition. Nº de ref. de la librería AAS9780812991840

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 12,43
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

5.

Robert Bazell
Editorial: Random House USA Inc, United States (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos Paperback Cantidad: 1
Librería
The Book Depository US
(London, Reino Unido)
Valoración
[?]

Descripción Random House USA Inc, United States, 1998. Paperback. Estado de conservación: New. 226 x 150 mm. Language: English . Brand New Book. Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield s aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech s clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn t otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient s bedside. Bazell s deft portraits introduce us to the remarkable people instrumental in Herceptin s history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon s research; and Marti Nelson, who inspired the activists who lobbied for a compassionate use program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition. Nº de ref. de la librería AAS9780812991840

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 12,43
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

6.

Bazell, Robert
Editorial: Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos PAPERBACK Cantidad: 2
Librería
Movie Mars
(Indian Trail, NC, Estados Unidos de America)
Valoración
[?]

Descripción Random House. PAPERBACK. Estado de conservación: New. 0812991842 Brand New Book. Ships from the United States. 30 Day Satisfaction Guarantee!. Nº de ref. de la librería 4242194

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 9,14
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 3,68
A Estados Unidos de America
Destinos, gastos y plazos de envío

7.

Bazell, Robert
Editorial: Random House 1998-01-01 (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos paperback Cantidad: 1
Librería
Blackwell's
(Oxford, OX, Reino Unido)
Valoración
[?]

Descripción Random House 1998-01-01, 1998. paperback. Estado de conservación: New. Nº de ref. de la librería 9780812991840

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 12,16
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 5,19
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

8.

Robert Bazell, Mary-Claire King
Editorial: Random House USA Inc
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos Paperback / softback Cantidad: 1
Librería
THE SAINT BOOKSTORE
(Southport, Reino Unido)
Valoración
[?]

Descripción Random House USA Inc. Paperback / softback. Estado de conservación: new. BRAND NEW, Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer, Robert Bazell, Mary-Claire King, Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. "From the Hardcover edition.". Nº de ref. de la librería B9780812991840

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 11,85
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,85
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

9.

Bazell, Robert
Editorial: Random House (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos Tapa blanda Cantidad: 1
Librería
English-Book-Service Mannheim
(Mannheim, Alemania)
Valoración
[?]

Descripción Random House, 1998. Estado de conservación: New. Nº de ref. de la librería TH9780812991840

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 12,80
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

10.

Robert Bazell
Editorial: Random House Inc (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuevos Paperback Cantidad: 2
Librería
Revaluation Books
(Exeter, Reino Unido)
Valoración
[?]

Descripción Random House Inc, 1998. Paperback. Estado de conservación: Brand New. 1st edition. 240 pages. 8.75x6.00x0.50 inches. In Stock. Nº de ref. de la librería z-0812991842

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 14,28
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,92
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

Existen otras copia(s) de este libro

Ver todos los resultados de su búsqueda